Literature DB >> 8821730

Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studies.

H Kuo1, D K Ingram, R G Crystal, A Mastrangeli.   

Abstract

We assessed the application of a replication deficient recombinant adenovirus vector as a retrograde tracer in neural pathway studies. The adenovirus vector, Ad. RSV betagal, containing the intracellular marker gene, beta-galactosidase, was injected directly into the laterodorsal striatum of rats. The retrograde transport of the vector from the injection site was clearly visible in the cerebral cortex, thalamic nucleus, and substantia nigra. No evidence for anterograde transport of the vector was found. When the vector was injected into the genu of the corpus callosum, little uptake of the vector by fibers was noted which suggested that uptake by fibers-of-passage should not be a problem in tracing studies. The present study demonstrates that adenoviral vectors can be useful retrograde tracers in the study of afferent connections within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821730     DOI: 10.1016/0006-8993(95)01065-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system.

Authors:  M Glatzel; E Flechsig; B Navarro; M A Klein; J C Paterna; H Büeler; A Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

3.  Cytoplasmic dynein mediates adenovirus binding to microtubules.

Authors:  Samir A Kelkar; K Kevin Pfister; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 4.  Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Authors:  Rachel J Sizemore; Sonja Seeger-Armbruster; Stephanie M Hughes; Louise C Parr-Brownlie
Journal:  J Neurophysiol       Date:  2016-02-17       Impact factor: 2.714

5.  Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector.

Authors:  U Blömer; L Naldini; T Kafri; D Trono; I M Verma; F H Gage
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

6.  Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.

Authors:  Vincent Mittoux; Stephane Ouary; Christelle Monville; Fabrice Lisovoski; Thomas Poyot; Francoise Conde; Carole Escartin; Regine Robichon; Emmanuel Brouillet; Marc Peschanski; Philippe Hantraye
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

7.  Atraumatic oral spray immunization with replication-deficient viral vector vaccines.

Authors:  Christiane Stahl-Hennig; Seraphin Kuate; Monika Franz; You S Suh; Heribert Stoiber; Ulrike Sauermann; Klara Tenner-Racz; Stephen Norley; Ki S Park; Young C Sung; Ralph Steinman; Paul Racz; Klaus Uberla
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

8.  Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression.

Authors:  Anthony N van den Pol; Koray Ozduman; Guido Wollmann; Winson S C Ho; Ian Simon; Yang Yao; John K Rose; Prabhat Ghosh
Journal:  J Comp Neurol       Date:  2009-10-20       Impact factor: 3.215

9.  Gene therapy: a potential approach for cancer pain.

Authors:  Chalonda R Handy; Christina Krudy; Nicholas Boulis
Journal:  Pain Res Treat       Date:  2011-06-09

10.  Axonal transport of adeno-associated viral vectors is serotype-dependent.

Authors:  E A Salegio; L Samaranch; A P Kells; G Mittermeyer; W San Sebastian; S Zhou; J Beyer; J Forsayeth; K S Bankiewicz
Journal:  Gene Ther       Date:  2012-03-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.